+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celyad - logo

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
From
Collaboration Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1200 Pages
  • Global
From
From
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
GMP Cell Therapy Consumables Global Market Report 2024 - Product Thumbnail Image

GMP Cell Therapy Consumables Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Natural Killer (NK) cell therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Natural Killer (NK) cell therapy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
Regenerative Medicine in Medical - Thematic Research - Product Thumbnail Image

Regenerative Medicine in Medical - Thematic Research

  • Report
  • July 2022
  • 40 Pages
  • Global
From
From
Loading Indicator